Lantheus, Insightec to partner

By staff writers

October 29, 2020 -- Lantheus Medical Imaging and MR-guided focused ultrasound (MRgFUS) developer Insightec have entered into an agreement under which Lantheus will provide Insightec with microbubbles to be used to evaluate treatment of glioblastoma and neurodegenerative conditions.

The microbubbles will be combined with Insightec's MRgFUS platform to deliver ultrasound energy deep in the brain, Lantheus said. The combination of microbubbles and focused ultrasound temporarily disrupts the blood-brain barrier, allowing for chemotherapeutic drugs to be delivered to glioblastoma patients, according to the firm.

Lantheus will supply the microbubbles and Insightec will handle regulatory submissions and marketing, Lantheus noted. The deal includes a transfer price and royalties.

Copyright © 2020

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking